Market Research Logo

Ablation Devices: Technologies and Global Markets

Ablation Devices: Technologies and Global Markets

The global market for ablation devices reached $2.8 billion in 2015. The market should reach $3.1 billion in 2016 and $5.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 11.6% from 2016 to 2021.

This report provides:
An overview of the global market for ablation devices.
Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
A breakdown of the market into segments such as types of technology, products, major market players, application, geography, and factors influencing demand.
A look at factors inhibiting market growth such as pricing, reimbursement policies, and stringent regulatory impositions.
Discussion covering the role of supply chain members from manufacturers to surgeons.
Profiles of major players in the industry.


SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global ablation market by technologies, product categories, therapeutic segments, key procedures and geographic markets. The report includes key technologies involved in thermal ablation techniques and nonthermal ablation techniques. The report discusses the role of supply chain members from manufacturers to surgeons. The report has an in-depth analysis of key companies operating in the global ablation market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and Japan.

The ablation devices market is mainly segmented into two classes: thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures as well as its further implication on the therapeutic area. These two segmentations are also discussed in detail for the given period. The market is segmented by geography into the North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Conmed, Varian Medical Systems Inc., Medtronic Inc., Boston Scientific Corp., Olympus Corp., Smith & Nephew, C.R. Bard Inc., and others.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVE
STUDY BACKGROUND
SCOPE OF THE REPORT
INTENDED AUDIENCE
SOURCE OF INFORMATION AND METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR ABLATION DEVICES BY REGION, 2015-2021 ($ MILLIONS)
CHAPTER 3 ABLATION MARKET OVERVIEW
ABLATION DEVICES: TECHNOLOGY TRENDS AND INNOVATIONS
TYPES OF CONVENTIONAL SURGICAL PROCEDURES AND DRAWBACKS
HEART SURGERY
PLASTIC SURGERY
BRAIN SURGERY
CANCER SURGERY
ORTHOPEDIC SURGERY
GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, FDA AND INTERNATIONAL REGULATORY AGENCIES
TABLE 1 DEVICES YET TO BE APPROVED FOR ATRIAL FIBRILLATION
TREATMENT
INDUSTRY STRUCTURE AND SUPPLY CHAIN PROCESS
ROLE OF MANUFACTURERS
ROLE OF DISTRIBUTORS
ROLE OF RESEARCH INSTITUTE AND CONSULTANTS
ROLE OF GOVERNMENT
ROLE OF HOSPITALS AND SURGEONS
DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES AND OTHER
PARAMETERS INFLUENCING MARKET GROWTH
INCIDENCE AND PREVALENCE OF CANCERS
TABLE 2 ESTIMATED CANCER DEMOGRAPHICS IN THE U.S., 2016
FIGURE 1 DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2014 (%)
INCIDENCE AND PREVALENCE RELATING TO CVDS
TABLE 3 CARDIOVASCULAR DEMOGRAPHICS IN THE U.S., 2012
TABLE 4 EUROPEAN UNION STATISTICS OF CIRCULATORY DISEASES, 2012
FIGURE 2 DEATHS DUE TO CARDIOVASCULAR DISEASES IN EUROPE, 2014 (%)
FIGURE 3 PREVALENCE OF CIRCULATORY DISEASES IN ADULTS IN THE U.S., AGE GROUP 18 YEARS AND OVER, 2014 (%)
INCIDENCE AND PREVALENCE RELATING TO OPHTHALMOLOGY
TABLE 5 VISUAL IMPAIRMENT STATISTICS IN THE U.S., 2015 AND 2050 FIGURE 4 CAUSES OF VISUAL IMPAIRMENT, 2014 (%)
FIGURE 5 NO. OF PEOPLE WITH VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS)
FDA GUIDELINES FOR SELECTED PRODUCTS
TABLE 6 FDA GUIDELINES FOR SELECTED ABLATION DEVICES
REIMBURSEMENT SCENARIO
CODING CHANGES FOR CARDIOLOGY
ABLATION CODES
TABLE 7 FDA GUIDELINES FOR SELECTED ABLATION DEVICES
TABLE 8 PHYSICIAN FEE SCHEDULE CODES
COMPARISON OF 2012 AND 2013 CODES
Case Study I
Scenario: Evaluation for a possibility of thrombus before the procedure.
TABLE 9 ATRIAL FIBRILLATION ABLATION FOR PULMONARY VEIN
ISOLATION
Case Study II
Scenario: Comprehensive diagnostics of electrophysiology evaluation
with stimulation of arrhythmia.
TABLE 10 DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY
MARKET DYNAMICS
TECHNOLOGICAL DEVELOPMENTS
HIGHER RISK OF CHRONIC ILLNESSES
FIGURE 6 WORLD MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008-2030 (%)
FIGURE 7 ESTIMATED NUMBER OF U.S. CANCER SURVIVORS BY SEX AND AGE, 2014 (MILLIONS)
TABLE 11 CANCER DEMOGRAPHICS IN EUROPE, 2012
ABLATION THERAPY REQUIRES LESS TIME
LESS DAMAGE AND BLOOD LOSS
RESTRAINTS FOR THE GLOBAL ABLATION DEVICES MARKET
PRESSURE FROM REGULATORY AGENCIES
INSURANCE SETTLEMENT ISSUES
OPPORTUNITIES AND CHALLENGES FOR THE ABLATION DEVICES MARKET
GROWING MARKETS IN EMERGING ECONOMIES
NEED TO ENHANCE AWARENESS LEVELS
CHAPTER 4 ABLATION MARKET ANALYSIS BY TECHNOLOGY
TABLE 12 GLOBAL MARKET FOR ABLATION DEVICES AND SERVICES, THROUGH 2021 ($ MILLIONS)
TABLE 13 GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
THERMAL TECHNOLOGY MARKET
TABLE 14 GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
ELECTRICAL ABLATION THERAPY
TABLE 15 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
RADIATION TECHNOLOGY
TABLE 16 GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
Types of Radiation Ablation Techniques
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Helical Tomography
Particle Therapy
Stereotactic Radiotherapy
Brachytherapy
RADIO FREQUENCY (RFID) TECHNOLOGY
TABLE 17 GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
Uses of RFA
Key Applications of RFA
Specific Application of RFID in Therapeutic Segments
Treatment of Liver Cancer
Treatment of Kidney Cancer
Treatment of Lung Cancer
Arrhythmias
Arthritis Pain
Treatment of Varicose Veins
LIGHT
TABLE 18 GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
ULTRASOUND
TABLE 19 GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 20 HIFU STUDIES IN KIDNEY TISSUES BY COUNTRY
HIFU in Prostate Cancer
HIFU in Primary and Secondary Liver Cancer
HIFU in Pancreatic Cancer
HIFU in Bladder Cancer
MICROWAVE
TABLE 21 GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
HYDROTHERMAL
TABLE 22 GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
NONTHERMAL ABLATION TECHNOLOGY
TABLE 23 GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY BY TYPE, THROUGH 2021 ($ MILLIONS)
CRYOABLATION
TABLE 24 GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
HYDROMECHANICAL
TABLE 25 GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 5 ABLATION MARKET ANALYSIS BY PRODUCTS
ELECTRICAL
TABLE 26 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TABLE 27 GLOBAL MARKET FOR ELECTRICAL ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
ELECTRICAL ABLATORS
TABLE 28 GLOBAL MARKET FOR ELECTRICAL ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
Argon Plasma/Beam Coagulator
TABLE 29 GLOBAL MARKET FOR ARGON PLASMA/BEAM COAGULATOR BY REGION, THROUGH 2021 ($ MILLIONS)
Irreversible Electroporation
TABLE 30 GLOBAL MARKET FOR IRREVERSIBLE ELECTROPORATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
ELECTRONIC BRACHYTHERAPY
TABLE 31 GLOBAL MARKET FOR ELECTRONIC BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
RADIATION
TABLE 32 GLOBAL MARKET FOR RADIATION THERAPY BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
BRACHYTHERAPY
TABLE 33 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY PRODUCTS, THROUGH 2021 ($ MILLIONS)
TABLE 34 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY REGION, THROUGH 2021 ($ MILLIONS)
High-Dose-Rate (HDR) Brachytherapy
TABLE 35 GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
Pulsed-Dose-Rate Brachytherapy
TABLE 36 GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
Permanent Seed Brachytherapy or Low-Dose-Rate (LDR) Brachytherapy
TABLE 37 GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
STEREOTACTIC RADIOSURGERY AND STEREOTACTIC RADIOTHERAPY
TABLE 38 GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) BY REGION, THROUGH 2021 ($ MILLIONS)
IMAGE-GUIDED RADIATION THERAPY (IGRT)
TABLE 39 GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY REGION, THROUGH 2021 ($ MILLIONS)
INTENSITY-MODULATED RADIATION THERAPY (IMRT)
TABLE 40 GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY REGION, THROUGH 2021 ($ MILLIONS)
STEREOTACTIC BODY RADIATION THERAPY (SBRT)
TABLE 41 GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY REGION, THROUGH 2021 ($ MILLIONS)
PROTON BEAM THERAPY
TABLE 42 GLOBAL MARKET FOR PROTON BEAM THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
RADIO FREQUENCY
TABLE 43 GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES
TABLE 44 GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
FLUID-COOLED RF ABLATION
TABLE 45 GLOBAL MARKET FOR FLUID-COOLED RF ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
THE ROBOTIC CATHETER MANIPULATION SYSTEM
TABLE 46 GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
LIGHT/LASER
TABLE 47 GLOBAL MARKET FOR LIGHT/LASER ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
COLD LASER
TABLE 48 GLOBAL MARKET FOR COLD LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
EXCIMER LASER
TABLE 49 GLOBAL MARKET FOR EXCIMER LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
ULTRASOUND
TABLE 50 GLOBAL MARKET FOR ULTRASOUND ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
TABLE 51 GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS)
TABLE 52 GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
ULTRASONIC SURGICAL SYSTEMS
TABLE 53 GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY REGION, THROUGH 2021 ($ MILLIONS)
EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
TABLE 54 GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY REGION, THROUGH 2021 ($ MILLIONS)
MICROWAVE ABLATION
HYDROTHERMAL ABLATION/ENDOMETRIAL HYDROTHERMAL BALLOON
ABLATION DEVICES
CRYOABLATION
TABLE 55 GLOBAL MARKET FOR CRYOABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TISSUE CONTACT PROBE
TABLE 56 GLOBAL MARKET FOR TISSUE CONTACT PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
TISSUE SPRAY PROBE
TABLE 57 GLOBAL MARKET FOR TISSUE SPRAY PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
TABLE 58 GLOBAL MARKET FOR EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
ADVANCEMENT IN ROBOTIC ABLATION TECHNIQUE
VARIOUS PROCEDURES THAT ARE ROBOTIC IN NATURE
STEERABLE CATHETERS
HEARTLANDER
ROBOTIC RADIOTHERAPY
ROBOTIC ABLATION FOR ARRHYTHMIA
LEADING ROBOTIC SYSTEMS USED IN CATHETER ABLATION
Niobe (Stereotaxis)
Sensei (Hansen Medical)
Amigo (Catheter Robotics)
Artis Zeego (Siemens)
TABLE 59 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TABLE 60 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 61 GLOBAL MARKET FOR AUTOMATED/ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 62 GLOBAL MARKET FOR CONVENTIONAL ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 6 ABLATION MARKET ANALYSIS BY PROCEDURES
TABLE 63 GLOBAL MARKET FOR ABLATION DEVICES BY PROCEDURE, THROUGH 2021 ($ MILLIONS)
AESTHETICS-SKIN REJUVENATION AND TIGHTENING
TABLE 64 GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY REGION, THROUGH 2021 ($ MILLIONS)
LASER SKIN REJUVENATION
ILLUSTRATION: SOURCE-VICTORIAN COSMETIC INSTITUTE'S CASE STUDIES
RADIO FREQUENCY (RF) FOR FACIAL SKIN REJUVENATION
AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE
TABLE 65 GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE BY REGION, THROUGH 2021 ($ MILLIONS)
HIFU FOR FAT REDUCTION
ILLUSTRATION: SOURCE-ELSEVIER HEALTH JOURNAL
VACUUM MASSAGE FOR CELLULITE REDUCTION
BENIGN PROSTATIC HYPERPLASIA
TABLE 66 GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA BY REGION, THROUGH 2021 ($ MILLIONS)
GREENLIGHT LASER PROCEDURE FOR BENIGN PROSTATE
ILLUSTRATIONS: SOURCE-EUROPEAN UROLOGY CENTER
THERMOTHERAPY FOR BENIGN PROSTATE
TRANSURETHRAL NEEDLE ABLATION
TABLE 67 GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
ILLUSTRATIONS: SOURCE-DIVISION OF UROLOGY, JOHANNESBURG
HOSPITAL, SOUTH AFRICA
LASER AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER
ABLATION/ENUCLEATION OF THE PROSTATE
HOLMIUM LASER ENUCLEATION OF PROSTATE CANCER
TABLE 68 GLOBAL MARKET FOR LASER AND OTHER ENERGY-BASED ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
ILLUSTRATION
ATRIAL FIBRILLATION ABLATION
TABLE 69 GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
PAROXYSMAL ATRIAL FIBRILLATION
PERSISTENT ATRIAL FIBRILLATION
CANCER/TUMOR ABLATION
TABLE 70 GLOBAL MARKET FOR TUMOR/CANCER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
MENORRHAGIA/ENDOMETRIAL ABLATION
TABLE 71 GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
HEATED BALLOON PROCEDURE
SPINAL DECOMPRESSION AND DENERVATION
TABLE 72 GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
DIAGNOSTIC MEDIAL BRANCH BLOCK (MBB)
RADIO FREQUENCY ABLATION (RFA) FOR BACK PAIN
STRESS URINARY INCONTINENCE
TABLE 73 GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
TRANSURETHRAL RADIO FREQUENCY COLLAGEN DENATURATION
VARICOSE VEIN ABLATION
TABLE 74 GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
RADIO FREQUENCY ABLATION (RFA) FOR VARICOSE VEINS
UTERINE FIBROIDS
TABLE 75 GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR TERINE FIBROIDS
OTHER PROCEDURES
TABLE 76 GLOBAL MARKET FOR OTHER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
ELASA EYE SURGERY
CHAPTER 7 ABLATION MARKET ANALYSIS BY THERAPEUTICS
TABLE 77 GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2021 ($ MILLIONS)
CANCER/ONCOLOGY
TABLE 78 GLOBAL MARKET FOR CANCER ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
CARDIOVASCULAR
TABLE 79 GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
OPHTHALMOLOGY
TABLE 80 GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
COSMETOLOGY
GYNECOLOGY
TABLE 81 GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
UROLOGY
TABLE 82 GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
CRYOABLATION FOR PROSTATE CANCER
ORTHOPEDICS
TABLE 83 GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
RADIO FREQUENCY ABLATION (RFA) FOR ORTHOPEDIC TREATMENT
PAIN MANAGEMENT
CRYOABLATION IN PAIN MANAGEMENT
OTHERS
TABLE 84 GLOBAL MARKET FOR OTHER THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
COBLATION FOR TONSILS
PORT-WINE STAINS
ABLATION OF PORT-WINE STAINS
CHAPTER 8 COMPETITIVE LANDSCAPE
FIGURE 8 KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
CLEARANCES AND APPROVALS
FIGURE 9 CLEARANCE AND APPROVAL STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 85 KEY CLEARANCES AND APPROVALS ANNOUNCED BETWEEN 2014 AND 2016
ACQUISITIONS
FIGURE 10 ACQUISITION STRATEGY BY COMPANIES, 2014-2016 (%)
TABLE 86 KEY ACQUISITIONS ANNOUNCED BETWEEN 2014 AND 2016
AGREEMENTS
FIGURE 11 AGREEMENT STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 87 KEY AGREEMENTS ANNOUNCED BETWEEN 2014 AND 2016
PRODUCT LAUNCH
FIGURE 12 PRODUCT LAUNCH STRATEGY BY COMPANIES, 2014-2016 (%)
TABLE 88 KEY PRODUCT LAUNCH ANNOUNCED BETWEEN 2014 AND 2016
CHAPTER 9 GEOGRAPHIC ANALYSIS
NORTH AMERICA
TABLE 89 NORTH AMERICA ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
EUROPE
TABLE 90 EUROPEAN ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
ASIA-PACIFIC
TABLE 91 ASIA-PACIFIC ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
ROW
TABLE 92 ROW ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
CHAPTER 10 PATENT ANALYSIS
FIGURE 13 SHARES OF PATENTS REGISTERED/APPROVED BY COUNTRY, 2013 THROUGH NOV. 2016 (%)
PATENT ANALYSIS BY MARKET PARTICIPANTS
FIGURE 14 PATENT SHARES BY MARKET PARTICIPANT, 2013 THROUGH NOV. 2016 (%)
PATENT ANALYSIS BY YEAR
FIGURE 15 PATENT ANALYSIS BY YEAR, 2013 THROUGH NOV. 2016 (%)
CHAPTER 11 COMPANY PROFILES
ABBOTT LABORATORIES
ABLATION PRODUCT PORTFOLIO
TABLE 93 ABBOTT LABORATORIES RECENT DEVELOPMENTS, 2014-2016
TABLE 94 ABBOTT LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%)
ACCURAY INC.
ACCURAY PRODUCT PORTFOLIO
TABLE 95 ACCURAY RECENT DEVELOPMENTS, 2014-2016
TABLE 96 ACCURAY FINANCIALS, 2013-2015 ($ MILLIONS/%)
ALCON LABORATORIES INC.
ABLATION PRODUCT PORTFOLIO
TABLE 97 ALCON RECENT DEVELOPMENTS, 2014-2016
TABLE 98 ALCON FINANCIALS, 2013-2015 ($ MILLIONS/%)
ANGIODYNAMICS INC.
ABLATION PRODUCT PORTFOLIO
TABLE 99 ANGIODYNAMICS RECENT DEVELOPMENTS, 2014-2016
TABLE 100 ANGIODYNAMICS FINANCIALS, 2013-2015 ($ MILLIONS/%)
ATRICURE INC.
ABLATION PRODUCT PORTFOLIO
TABLE 101 ATRICURE RECENT DEVELOPMENTS, 2014-2016
TABLE 102 ATRICURE FINANCIALS, 2013-2015 ($ MILLIONS/%)
BIOSENSE WEBSTER
ABLATION PRODUCT PORTFOLIO
TABLE 103 BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2014-2016
TABLE 104 BIOSENSE WEBSTER FINANCIALS, 2013-2015 ($ MILLIONS/%)
BOSTON SCIENTIFIC CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 105 BOSTON SCIENTIFIC CORP. RECENT DEVELOPMENTS, 2014-2016
TABLE 106 BOSTON SCIENTIFIC CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
BTG PLC
ABLATION PRODUCT PORTFOLIO
TABLE 107 BTG PLC RECENT DEVELOPMENTS, 2014-2016
TABLE 108 BTG PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
CONMED CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 109 CONMED RECENT DEVELOPMENTS, 2014-2016
TABLE 110 CONMED FINANCIALS, 2013-2015 ($ MILLIONS/%)
C.R. BARD INC.
ABLATION PRODUCT PORTFOLIO
TABLE 111 C.R. BARD RECENT DEVELOPMENTS, 2014-2016
TABLE 112 C.R. BARD FINANCIALS, 2013-2015 ($ MILLIONS/%)
EDAP TMS S.A.
ABLATION PRODUCT PORTFOLIO
TABLE 113 EDAP TMS S.A. RECENT DEVELOPMENTS, 2014-2016
TABLE 114 EDAP TMS S.A. FINANCIALS, 2013-2015 ($ MILLIONS/%)
ELEKTA AB
ABLATION PRODUCT PORTFOLIO
TABLE 115 ELEKTA AB RECENT DEVELOPMENTS, 2014-2016
TABLE 116 ELEKTA AB FINANCIALS, 2013-2015 ($ MILLIONS/%)
HAYLARD HEALTH INC.
ABLATION PRODUCT PORTFOLIO
TABLE 117 HAYLARD HEALTH INC. RECENT DEVELOPMENTS, 2014-2016
TABLE 118 HAYLARD HEALTH INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
HOLOGIC INC.
ABLATION PRODUCT PORTFOLIO
TABLE 119 HOLOGIC INC. RECENT DEVELOPMENTS, 2014-2016
TABLE 120 HOLOGIC INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
INTEGRA LIFESCIENCES HOLDINGS CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 121 INTEGRA LIFESCIENCES HOLDINGS CORP. RECENT DEVELOPMENTS, 2014-2016
TABLE 122 INTEGRA LIFESCIENCES HOLDINGS CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
JAPAN LIFELINE CO. LTD.
ABLATION PRODUCT PORTFOLIO
TABLE 123 JAPAN LIFELINE CO. LTD. RECENT DEVELOPMENTS, 2014-2016
TABLE 124 JAPAN LIFELINE CO. LTD. FINANCIALS, 2013-2015 ($ MILLIONS/%)
MEDTRONIC PLC
ABLATION PRODUCT PORTFOLIO
TABLE 125 MEDTRONIC PLC RECENT DEVELOPMENTS, 2014-2016
TABLE 126 MEDTRONIC PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
MERIT MEDICAL SYSTEMS INC.
ABLATION PRODUCT PORTFOLIO
TABLE 127 MERIT MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
TABLE 128 MERIT MEDICAL SYSTEMS INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
MISONIX INC.
ABLATION PRODUCT PORTFOLIO
TABLE 129 MISONIX INC. RECENT DEVELOPMENTS, 2014-2016
TABLE 130 MISONIX FINANCIALS, 2013-2015 ($ MILLIONS/%)
OLYMPUS CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 131 OLYMPUS RECENT DEVELOPMENTS, 2014-2016
TABLE 132 OLYMPUS FINANCIALS, 2013-2015 ($ MILLIONS/%)
SMITH & NEPHEW PLC
ABLATION PRODUCT PORTFOLIO
TABLE 133 SMITH & NEPHEW RECENT DEVELOPMENTS, 2014-2016
TABLE 134 SMITH & NEPHEW FINANCIALS, 2013-2015 ($ MILLIONS/%)
ST. JUDE MEDICAL INC.
ABLATION PRODUCT PORTFOLIO
TABLE 135 ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2014-2016
TABLE 136 ST. JUDE MEDICAL FINANCIALS, 2013-2015 ($ MILLIONS/%)
STRYKER CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 137 STRYKER CORP. RECENT DEVELOPMENTS, 2014-2016
TABLE 138 STRYKER CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
TERUMO MEDICAL CORP.
ABLATION PRODUCT PORTFOLIO
TABLE 139 TERUMO MEDICAL CORP. RECENT DEVELOPMENTS, 2014-2016
TABLE 140 TERUMO MEDICAL CORP. FINANCIALS, 2013-2015 ($
MILLIONS/%)
VARIAN MEDICAL SYSTEMS INC.
ABLATION PRODUCT PORTFOLIO
TABLE 141 VARIAN MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
TABLE 142 VARIAN MEDICAL SYSTEMS INC., 2013-2015 ($ MILLIONS/%)
CHAPTER 12 APPENDIX
TABLE 143 U.S. PATENTS, 2013 THROUGH OCT. 2016
TABLE 144 EUROPEAN PATENTS, 2013 THROUGH NOV. 2016
TABLE 145 JAPANESE PATENTS, 2013-2015
TABLE 146 CHINESE PATENTS, 2013-2015
TABLE 147 CANADIAN PATENTS, 2013-2015
TABLE 148 ROW PATENTS, 2013-2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report